Haemolytic disease of the newborn (HDN) can be associated with significant morbidity.
Prompt treatment with intensive phototherapy (PT) and exchange transfusions (ETs) can …

Objectives: To assess the effectiveness of high dose intravenous immunoglobulin (HDIVIG)
in reducing the need for exchange transfusion in neonates with proven haemolytic disease …

Background Intravenous immunoglobulin (IVIg) is used in neonates with isoimmune
haemolytic disease to prevent exchange transfusion (ET). However, studies supporting IVIg …

Background Exchange transfusion and phototherapy have traditionally been used to treat
jaundice and avoid the associated neurological complications. Because of the risks and …

Intravenous immunoglobulin (IVIG) is indicated for use in Rhesus and ABO hemolytic
disease of the newborn (HDN) to reduce the need for exchange transfusion, to decrease …

Alloimmune hemolytic disease of the newborn (AIHDN) results in hemolysis, anemia,
hyperbilirubinemia with the potential for brain damage. Intravenous immunoglobulin (IVIG) …

Objective To evaluate the efficacy and safety of intravenous immunoglobulin G (IVIG) in
infants with ABO hemolytic disease of the newborn (HDN). Methods Infants with moderate-to …

Phototherapy is the standard treatment in moderately severe hemolytic disease of newborn
(HDN), whereas exchange transfusion (ET) is the second line in progressive cases …

Background: Despite advances made in the use of phototherapy, and in order to avoid
sequelae of kernicterus, the treatment of hyperbilirubinemia may require one or several …

Background: Although intravenous immunoglobulin G (IVIG) therapy has been reported in
hyperbilirubinemia of Rh hemolytic disease, its use in ABO hemolytic disease has been …